{ "schemaVersion": 2, "eyebrow": "Neurocritical Care", "title": "Intracranial Hypertension", "summary": "Intracranial hypertension requires rapid separation of mass effect, hydrocephalus, hemorrhage, venous thrombosis, and idiopathic disease; management prioritizes herniation prevention, cerebral perfusion, etiologic imaging, and vision-preserving intervention when papilledema or progressive visual loss is present.", "seoDescription": "Point-of-care approach to intracranial hypertension: urgent imaging, safe lumbar puncture, ICP-directed therapy, and idiopathic intracranial hypertension management.", "clinicalQuestion": "How should physicians identify dangerous intracranial hypertension, establish its cause, and select urgent ICP- and vision-directed interventions?", "specialty": "Neurology and Neurocritical Care", "audience": "U.S. physicians and medical trainees", "tags": [ "intracranial hypertension", "raised intracranial pressure", "idiopathic intracranial hypertension", "papilledema", "cerebral venous sinus thrombosis", "hypertonic saline", "mannitol", "intracranial pressure monitoring" ], "keyTakeaways": [ "Obtain neuroimaging before lumbar puncture when intracranial mass, hydrocephalus, or another structural cause is possible; lumbar puncture in that setting can precipitate downward herniation. [20][23]", "In adults, a lumbar puncture opening pressure greater than 250 mm CSF supports raised intracranial pressure, but definite pseudotumor cerebri syndrome also requires papilledema or abducens palsy and appropriate imaging and CSF findings. [23][24]", "MRI with venous imaging distinguishes idiopathic intracranial hypertension from structural lesions and cerebral venous sinus thrombosis; MRI signs of IIH support but do not exclude the diagnosis when absent. [22][24]", "For acute elevated ICP, hypertonic saline and mannitol both reduce ICP; pooled randomized data found a modest relative advantage for hypertonic saline, while clinical magnitude of difference was uncertain. [2][16]", "In IIH, escalating visual dysfunction despite medical treatment warrants urgent vision-directed procedural management; CSF diversion for headache alone should not be routine. [3][23]" ], "sections": [ { "id": "triage-and-stabilization", "eyebrow": "Immediate Threats", "heading": "Identify patients who need emergent ICP-directed care", "intro": "Treat suspected acute intracranial hypertension as a time-sensitive threat while defining the lesion.", "paragraphs": [ "In acute brain injury, prioritize immediate brain imaging and assessment for a surgically remediable process—intracranial hemorrhage, mass lesion, hydrocephalus, or diffuse edema—rather than waiting for lumbar puncture confirmation. Elevated ICP can reduce cerebral perfusion and contribute to secondary ischemic injury; contemporary neurocritical care targets commonly emphasize cerebral perfusion pressure of 60–70 mmHg. [10][20]", "Use invasive ICP monitoring when management depends on continuous ICP assessment, particularly in severe traumatic brain injury and in patients proceeding through escalating tiered therapy. ICP of at least 15 mmHg has been associated with adverse neurologic outcomes, although the measurement requires invasive monitoring. [7][8]", "If documented or strongly suspected ICP elevation requires osmotherapy, use either hypertonic saline or mannitol according to hemodynamic context and local protocol. Mannitol can lower mean arterial pressure; hypertonic saline may better preserve or increase arterial pressure. A meta-analysis of five small unblinded randomized trials found a relative risk of 1.16 favoring hypertonic saline for ICP reduction, but the absolute difference in ICP reduction was not clinically significant. [2][16]" ], "bullets": [ "Do not perform lumbar puncture until imaging has excluded a mass lesion capable of causing downward herniation. [20][23]", "Escalate to ventricular drainage, decompressive craniectomy, or other neurosurgical intervention when hydrocephalus, mass effect, or medically refractory intracranial hypertension is identified. [4][7]", "Interpret osmotherapy response as temporizing ICP control, not etiologic treatment; continue imaging-based and neurosurgical evaluation in parallel. [2][7]" ], "subsections": [], "table": { "caption": "Immediate management branch points in suspected intracranial hypertension. [2][7][20][23]", "columns": [ "Clinical branch", "Immediate next action", "Decision consequence" ], "rows": [ [ "Acute neurologic deterioration or suspected structural lesion", "Urgent CT or MRI; involve neurosurgery when hemorrhage, mass effect, or hydrocephalus is present. [20]", "Defer lumbar puncture until imaging excludes a lesion that could cause herniation. [20][23]" ], [ "Severe brain injury with ICP-directed management", "Use invasive ICP monitoring when continuous ICP data will guide tiered escalation. [7][8]", "Maintain cerebral perfusion while treating ICP; CPP targets commonly fall within 60–70 mmHg. [10]" ], [ "Acute ICP elevation requiring osmotherapy", "Select hypertonic saline or mannitol; account for mannitol-associated reduction in mean arterial pressure. [2]", "Hypertonic saline showed modestly greater ICP-response probability in pooled trials, without a clinically significant difference in reduction magnitude. [2][16]" ] ] } }, { "id": "diagnostic-workup", "eyebrow": "Diagnostic Pathway", "heading": "Use imaging first, then confirm pressure and cause", "intro": "The diagnostic sequence should prevent herniation and distinguish secondary disease from IIH.", "paragraphs": [ "For chronic or subacute intracranial hypertension, obtain brain MRI with and without contrast when feasible to assess for hydrocephalus, parenchymal mass, structural disease, and meningeal enhancement. CT may be the initial rapid study, but MRI provides more detailed evaluation of chronic intracranial causes. [20][22]", "Add MR venography or CT venography when IIH is being considered because cerebral venous sinus thrombosis must be excluded before labeling the syndrome idiopathic. Venous imaging can also demonstrate transverse sinus stenosis, an imaging association of IIH rather than a stand-alone diagnostic finding. [21][22][24]", "After imaging has excluded a mass lesion, perform lumbar puncture with opening-pressure measurement and CSF analysis for infectious or inflammatory etiologies. In adults and nonsedated normal-weight children, opening pressure greater than 250 mm CSF is abnormal; in children, greater than 280 mm CSF is abnormal. Opening pressure alone is insufficient for a definite pseudotumor cerebri syndrome diagnosis. [20][23]" ], "bullets": [ "Document papilledema with formal ophthalmic assessment; optical coherence tomography can help quantify optic nerve head and retinal nerve fiber layer changes. [21][23]", "An abducens palsy can satisfy the neurologic abnormality criterion for definite pseudotumor cerebri syndrome when paired with the appropriate pressure, imaging, and CSF profile. [23]", "When papilledema is absent but suspicion remains high, do not dismiss IIH solely because OCT or CT is unrevealing; MRI/MRV and lumbar puncture may establish the diagnosis. [21]" ], "subsections": [ { "heading": "Imaging findings that support IIH", "paragraphs": [ "MRI findings supporting IIH include partial or empty sella, posterior globe flattening, optic nerve protrusion, optic nerve tortuosity, perioptic CSF-space distension, and transverse venous sinus stenosis. Their absence does not rule out IIH, so use them as supportive evidence after excluding mass lesion and venous thrombosis. [22][24]" ], "bullets": [] } ], "table": { "caption": "Diagnostic patterns that redirect the workup of raised ICP. [20][22][23][24]", "columns": [ "Pattern", "Key tests or findings", "Interpretation and next step" ], "rows": [ [ "Mass lesion, hydrocephalus, or structural abnormality", "CT or MRI identifies structural pathology. [20][22]", "Avoid lumbar puncture before lesion-specific stabilization and neurosurgical assessment. [20][23]" ], [ "Possible cerebral venous sinus thrombosis", "MRV or CTV demonstrates venous thrombosis. [22][24]", "This is secondary intracranial hypertension; do not diagnose IIH until thrombosis is excluded. [22][24]" ], [ "IIH-compatible syndrome", "Normal brain parenchyma without hydrocephalus, mass, structural lesion, or abnormal meningeal enhancement; elevated opening pressure; normal CSF; no secondary cause. [22][24]", "Assess papilledema, visual fields, and optic nerve status to determine urgency of vision-directed treatment. [23]" ], [ "Persistent symptoms without papilledema", "MRI/MRV may show empty sella, optic nerve sheath distension, posterior scleral flattening, or transverse sinus narrowing; LP can demonstrate elevated pressure. [21]", "Use the complete syndrome criteria rather than pressure or imaging in isolation. [23][24]" ] ] } }, { "id": "secondary-causes", "eyebrow": "Etiologic Branches", "heading": "Separate secondary intracranial hypertension from IIH", "intro": "A diagnosis of IIH follows exclusion of structural, venous, infectious, and inflammatory causes.", "paragraphs": [ "Structural intracranial hypertension is suggested by hydrocephalus, intraparenchymal lesion, mass effect, or abnormal meningeal enhancement on imaging. These findings redirect care toward the underlying lesion and away from diagnostic lumbar puncture until herniation risk is addressed. [20][22]", "Cerebral venous sinus thrombosis is the central imaging exclusion in suspected IIH. Obtain MRV when feasible or CTV when MRI cannot be performed; transverse sinus stenosis may accompany IIH, whereas venous thrombosis establishes a secondary cause. [22][24]", "Infectious and inflammatory etiologies require CSF evaluation after safe imaging. The IIH diagnostic framework requires normal CSF composition and absence of another secondary cause; abnormal CSF should redirect evaluation to the identified inflammatory or infectious process rather than IIH. [20][22][24]" ], "bullets": [ "Use MRI with and without gadolinium to evaluate abnormal meningeal enhancement when chronic raised ICP is under evaluation. [22]", "Do not treat imaging signs such as empty sella or transverse sinus stenosis as diagnostic in isolation. [24]", "In infants, a bulging fontanelle or widened cranial sutures can indicate elevated ICP; papilledema may be absent because open sutures accommodate pressure. [20]" ], "subsections": [], "table": { "caption": "Etiologic distinction determines whether management is lesion-directed, CSF-diverting, or IIH-directed. [20][22][24]", "columns": [ "Etiologic category", "Discriminating evidence", "Management direction" ], "rows": [ [ "Structural lesion or hydrocephalus", "Abnormal CT or MRI showing hydrocephalus, mass, or parenchymal structural disease. [20][22]", "Urgent neurosurgical and lesion-specific management; avoid pre-imaging LP. [20][23]" ], [ "Cerebral venous sinus thrombosis", "MRV or CTV shows thrombosis. [22][24]", "Treat as secondary intracranial hypertension rather than IIH. [22][24]" ], [ "Infectious or inflammatory process", "CSF composition is abnormal after imaging permits LP. [20][22]", "Direct treatment to CSF-defined etiology. [20][22]" ], [ "Idiopathic intracranial hypertension", "Elevated opening pressure, normal CSF, no mass lesion or venous thrombosis, and appropriate clinical syndrome. [22][23][24]", "Protect vision and manage ICP-related disease; treat coexisting headache phenotype separately. [3][23]" ] ] } }, { "id": "iih-management", "eyebrow": "Vision Protection", "heading": "Manage IIH according to visual risk, not headache alone", "intro": "Visual function determines procedural urgency in IIH.", "paragraphs": [ "Establish a definite IIH or pseudotumor cerebri syndrome diagnosis with the combined clinical, imaging, and lumbar puncture profile. Either papilledema or abducens palsy is required for a definite diagnosis; an elevated opening pressure alone is inadequate. [23]", "For IIH with papilledema, follow visual acuity and formal visual fields because progressive field loss can occur despite symptomatic headache improvement. In a reported management example, worsening visual fields after acetazolamide 500 mg twice daily led to dose escalation and optic nerve sheath fenestration within one week, followed by visual improvement. [23]", "Acetazolamide dosing is not standardized in the consensus guidance, and periodic serum electrolyte monitoring is recommended in licensing information without a consensus interval. Topiramate may be considered when its carbonic anhydrase activity, appetite suppression, and migraine efficacy are clinically useful; suggested escalation is 25 mg weekly to 50 mg twice daily. This use rests on limited IIH-specific comparative evidence. [3]" ], "bullets": [ "Choose optic nerve sheath fenestration when vision is threatened and rapid optic nerve protection is needed; the procedure improved vision in a reported patient with progressive field loss despite acetazolamide. [23]", "Do not use CSF diversion procedures as routine treatment for headache alone; consider diversion for headache only in a multidisciplinary setting after a period of ICP monitoring. [3]", "In a patient with an existing shunt and recurrent headache, assess for papilledema, shunt failure, and overdrainage; do not routinely revise a shunt without papilledema and risk of visual deterioration. [3]" ], "subsections": [ { "heading": "Headache-predominant disease", "paragraphs": [ "IIH headache often has a superimposed migrainous component. Treat the headache phenotype while ensuring ICP and visual status are adequately assessed; CSF diversion may fail to relieve headache when migraine is the dominant residual driver. [3]" ], "bullets": [] } ], "table": { "caption": "IIH management decisions by visual status and symptom pattern. [3][23]", "columns": [ "Clinical situation", "Action", "Important limitation" ], "rows": [ [ "Papilledema with stable visual assessment", "Initiate medical ICP-directed treatment and serial visual assessment; acetazolamide is used clinically, but optimal dose is not established. [3]", "Monitor serum electrolytes periodically; no consensus monitoring interval is specified. [3]" ], [ "Progressive visual field or acuity loss", "Escalate urgently to vision-preserving intervention such as optic nerve sheath fenestration. [23]", "Do not use symptom improvement alone as evidence that visual risk has resolved. [23]" ], [ "Headache-predominant IIH without documented visual decline", "Treat migrainous headache contributors; consider topiramate with weekly escalation from 25 mg to 50 mg twice daily when appropriate. [3]", "CSF diversion should not be routine for headache alone. [3]" ], [ "Shunted patient with recurrent headache", "Evaluate for papilledema, shunt failure, and overdrainage. [3]", "Avoid routine shunt revision without papilledema and risk of visual deterioration. [3]" ] ] } }, { "id": "monitoring-and-escalation", "eyebrow": "Follow-up", "heading": "Monitor the organ at risk and escalate on objective deterioration", "intro": "Follow objective ICP, imaging, and visual measures rather than symptoms alone.", "paragraphs": [ "In acute neurocritical illness, use continuous invasive ICP data when it changes escalation decisions and track cerebral perfusion alongside ICP. Sustained intracranial hypertension increases risk of secondary cerebral ischemia, which is why ICP-directed treatment must be coordinated with blood-pressure support and lesion control. [7][10]", "In IIH, repeat ophthalmic assessments when papilledema is present or visual symptoms change. Visual field worsening should prompt treatment escalation even if headache improves, whereas recurrent headache in a shunted patient without papilledema should trigger evaluation for overdrainage or shunt dysfunction before elective revision. [3][23]", "When serial symptoms and examination remain discordant, revisit the etiologic diagnosis with MRI/MRV and safe lumbar puncture rather than attributing persistent symptoms to IIH on the basis of isolated radiologic signs or opening pressure. [21][23][24]" ], "bullets": [ "Use ICP monitoring and EVD use as part of stepwise escalation in severe traumatic brain injury when refractory ICP elevation is driving consideration of decompressive craniectomy. [7]", "Reassess for shunt failure and overdrainage in shunted IIH patients with recurrent headache. [3]", "Reconfirm absence of venous thrombosis before maintaining an IIH diagnosis when venous imaging has not been completed. [22][24]" ], "subsections": [], "table": { "caption": "Objective findings that should trigger reassessment or escalation. [3][7][23][24]", "columns": [ "Finding", "Interpretation", "Next step" ], "rows": [ [ "ICP elevation despite medical measures in severe brain injury", "Potential refractory intracranial hypertension. [7]", "Use tiered escalation with ICP monitoring; consider EVD or decompressive intervention in the appropriate surgical context. [7]" ], [ "Progressive visual-field impairment in IIH", "Ongoing optic nerve risk despite medical therapy. [23]", "Urgently pursue vision-preserving procedural escalation. [23]" ], [ "Headache after CSF shunt without papilledema", "Headache may reflect overdrainage, shunt dysfunction, or migraine rather than recurrent vision-threatening ICP elevation. [3]", "Evaluate those mechanisms; do not routinely revise the shunt. [3]" ], [ "IIH-like MRI signs with uncertain syndrome", "Imaging is supportive but not definitive. [24]", "Complete venous imaging and, after safe imaging, LP with CSF evaluation. [20][22][24]" ] ] } } ], "faq": [], "references": [ { "number": 1, "title": "Traumatic brain injury: progress and challenges in ...", "detail": "www.thelancet.com", "url": "https://www.thelancet.com/article/S1474-4422(22)00309-X/fulltext", "authors": "www.thelancet.com", "host": "www.thelancet.com" }, { "number": 2, "title": "Hypertonic Saline vs. Mannitol for Treating Elevated Intracranial Pressure | NEJM Clinician", "detail": "clinician.nejm.org", "url": "https://clinician.nejm.org/hypertonic-saline-vs-mannitol-treating-elevated-intracranial-pressure-EM201103180000001", "authors": "clinician.nejm.org", "host": "clinician.nejm.org" }, { "number": 3, "title": "Idiopathic intracranial hypertension: consensus guidelines on management", "detail": "jnnp.bmj.com", "url": "https://jnnp.bmj.com/content/89/10/1088", "authors": "jnnp.bmj.com", "host": "jnnp.bmj.com" }, { "number": 4, "title": "Supplementary file 5", "detail": "bmjopen.bmj.com", "url": "https://bmjopen.bmj.com/content/bmjopen/14/4/e078622/DC5/embed/inline-supplementary-material-5.pdf?download=true", "authors": "bmjopen.bmj.com", "host": "bmjopen.bmj.com" }, { "number": 5, "title": "Hypertonic Saline for Poor-Grade SAH | NEJM Clinician", "detail": "clinician.nejm.org", "url": "https://clinician.nejm.org/hypertonic-saline-poor-grade-sah-JN200308080000002", "authors": "clinician.nejm.org", "host": "clinician.nejm.org" }, { "number": 6, "title": "Hypertonic lactate for the treatment of intracranial ...", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-022-07129-z", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 7, "title": "Timing of decompressive craniectomy and short-term outcomes in pediatric severe traumatic brain injury: a nationwide observational study in Germany | Scientific Reports", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-026-35837-3", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 8, "title": "Derivation, external and clinical validation of a deep ...", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41746-024-01227-0", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 9, "title": "Hydrocephalus Management in Pediatric Posterior Fossa ...", "detail": "www.nature.com", "url": "https://www.nature.com/nature-index/topics/l4/hydrocephalus-management-in-pediatric-posterior-fossa-tumors", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 10, "title": "Evolving concepts in intracranial pressure monitoring", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S1878747924001946", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 11, "title": "Current Challenges in Neurocritical Care: A Narrative Review", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S187887502401667X", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 12, "title": "Injuria cerebral precoz en la hemorragia subaracnoidea ...", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0716864025000549", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 13, "title": "Neurocardiology: Major mechanisms and effects", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0022073624003066", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 14, "title": "Decoding Stroke Etiology: Multi‐Omics Advancements in ...", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/10.1002/brb3.70792", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com" }, { "number": 15, "title": "Papilledema is not the point: intracranial pressure ...", "detail": "academic.oup.com", "url": "https://academic.oup.com/braincomms/article/8/4/fcag259/8726050", "authors": "academic.oup.com", "host": "academic.oup.com" }, { "number": 16, "title": "Hypertonic saline versus mannitol for the... : Critical Care ...", "detail": "journals.lww.com", "url": "https://journals.lww.com/ccmjournal/fulltext/2011/03000/hypertonic_saline_versus_mannitol_for_the.18.aspx", "authors": "journals.lww.com", "host": "journals.lww.com" }, { "number": 17, "title": "Role of hypertonic saline and mannitol in the...", "detail": "journals.lww.com", "url": "https://journals.lww.com/jopn/fulltext/2010/05010/role_of_hypertonic_saline_and_mannitol_in_the.3.aspx", "authors": "journals.lww.com", "host": "journals.lww.com" }, { "number": 18, "title": "Hypertonic Saline Associated with Superior Intracranial ...", "detail": "journals.lww.com", "url": "https://journals.lww.com/neurotodayonline/blog/breakingnews/pages/post.aspx?PostID=1218", "authors": "journals.lww.com", "host": "journals.lww.com" }, { "number": 19, "title": "Comparison of Equimolar Doses of Mannitol and ...", "detail": "journals.lww.com", "url": "https://journals.lww.com/md-journal/_layouts/15/oaks.journals/downloadpdf.aspx?an=00005792-201505010-00004", "authors": "journals.lww.com", "host": "journals.lww.com" }, { "number": 20, "title": "Intracranial Hypertension - StatPearls - NCBI Bookshelf - NIH", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK507811", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov" }, { "number": 21, "title": "Idiopathic Intracranial Hypertension Without Papilledema: A Case Emphasizing the Diagnostic Value of Optic Nerve Sheath Ultrasound", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12357743", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov" }, { "number": 22, "title": "Idiopathic intracranial hypertension in children: Diagnostic and management approach - PMC", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5237838", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov" }, { "number": 23, "title": "Papilledema and Idiopathic Intracranial Hypertension", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10564025", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov" }, { "number": 24, "title": "MRI findings as markers of idiopathic intracranial hypertension", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7856277", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov" } ], "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.", "citations": [ { "number": 1, "title": "Traumatic brain injury: progress and challenges in ...", "detail": "www.thelancet.com", "url": "https://www.thelancet.com/article/S1474-4422(22)00309-X/fulltext", "authors": "www.thelancet.com", "host": "www.thelancet.com", "snippet": "by AIR Maas · 2022 · Cited by 1939 — Visualizing the pressure and time burden of intracranial hypertension in adult and paediatric traumatic brain injury Intensive Care Med.", "score": 0.44666424 }, { "number": 2, "title": "Hypertonic Saline vs. Mannitol for Treating Elevated Intracranial Pressure | NEJM Clinician", "detail": "clinician.nejm.org", "url": "https://clinician.nejm.org/hypertonic-saline-vs-mannitol-treating-elevated-intracranial-pressure-EM201103180000001", "authors": "clinician.nejm.org", "host": "clinician.nejm.org", "snippet": "###### Topics\n\nMannitol is standard treatment for suspected elevated intracranial pressure (ICP), but it has been implicated in undesirable reductions in mean arterial blood pressure. Researchers performed a meta-analysis of five unblinded randomized trials that compared equiosmolar doses of mannito", "score": 0.5663309 }, { "number": 3, "title": "Idiopathic intracranial hypertension: consensus guidelines on management", "detail": "jnnp.bmj.com", "url": "https://jnnp.bmj.com/content/89/10/1088", "authors": "jnnp.bmj.com", "host": "jnnp.bmj.com", "snippet": "##### Uncertainties\n\nThe optimal dose of acetazolamide is not established. The licencing information regarding acetazolamide recommends periodic monitoring of serum electrolytes; however, there is no consensus on the timing of monitoring.\n\n#### Q10 Are there other drugs that are helpful in IIH?\n\nTop", "score": 0.54187006 }, { "number": 4, "title": "Supplementary file 5", "detail": "bmjopen.bmj.com", "url": "https://bmjopen.bmj.com/content/bmjopen/14/4/e078622/DC5/embed/inline-supplementary-material-5.pdf?download=true", "authors": "bmjopen.bmj.com", "host": "bmjopen.bmj.com", "snippet": "craniectomy; Ventricular drainage ・ monitoring of intracranial pressure) craniectomy or Ventricular drainage ・ craniectomy or Ventricular drainage.", "score": 0.5066652 }, { "number": 5, "title": "Hypertonic Saline for Poor-Grade SAH | NEJM Clinician", "detail": "clinician.nejm.org", "url": "https://clinician.nejm.org/hypertonic-saline-poor-grade-sah-JN200308080000002", "authors": "clinician.nejm.org", "host": "clinician.nejm.org", "snippet": "Copyright © 2026\n\nMassachusetts Medical Society.\n\nAll rights reserved, including those for text and data mining, AI training, and similar technologies.\n\nElectronic ISSN 3067-1876\n\nThe content of this site is intended for health care professionals.\n\n# Hypertonic Saline for Poor-Grade SAH\n\nHypertonic ", "score": 0.43266314 }, { "number": 6, "title": "Hypertonic lactate for the treatment of intracranial ...", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-022-07129-z", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "by A Bernini · 2022 · Cited by 26 — Hypertonic saline (HS) is widely used for the treatment of elevated intracranial pressure (ICP), with demonstrated effectiveness in reducing ICP", "score": 0.4942147 }, { "number": 7, "title": "Timing of decompressive craniectomy and short-term outcomes in pediatric severe traumatic brain injury: a nationwide observational study in Germany | Scientific Reports", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-026-35837-3", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "Article\n19 August 2026\n\n## Introduction\n\nDecompressive craniectomy (DC) has emerged as a rescue measure to relieve refractory intracranial hypertension and prevent secondary cerebral ischemia or herniation in children with severe traumatic brain injury (sTBI). Primary DC, performed in the initial ph", "score": 0.46322632 }, { "number": 8, "title": "Derivation, external and clinical validation of a deep ...", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41746-024-01227-0", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "by F Gulamali · 2024 · Cited by 11 — Increased intracranial pressure (ICP) ≥15 mmHg is associated with adverse neurological outcomes, but needs invasive intracranial monitoring.", "score": 0.3607373 }, { "number": 9, "title": "Hydrocephalus Management in Pediatric Posterior Fossa ...", "detail": "www.nature.com", "url": "https://www.nature.com/nature-index/topics/l4/hydrocephalus-management-in-pediatric-posterior-fossa-tumors", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "Effective management aims to relieve intracranial pressure, reduce perioperative morbidity and limit long-term dependency on cerebrospinal fluid (CSF) diversion", "score": 0.35615602 }, { "number": 10, "title": "Evolving concepts in intracranial pressure monitoring", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S1878747924001946", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "by R Mathur · 2025 · Cited by 20 — Effective ICP management focuses on maintaining CPP to prevent secondary brain injury, often targeting a CPP of 60–70 ​mmHg based on clinical guidelines [42][43]", "score": 0.5786631 }, { "number": 11, "title": "Current Challenges in Neurocritical Care: A Narrative Review", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S187887502401667X", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "by S Kaleem · 2025 · Cited by 5 — In addition to the direct risk of mortality caused by elevated intracranial pressure (ICP) and hydrocephalus during the acute phase of hemorrhage, which may", "score": 0.49802306 }, { "number": 12, "title": "Injuria cerebral precoz en la hemorragia subaracnoidea ...", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0716864025000549", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "by A Reccius-Meza · 2025 — EBI is characterized by a multifactorial cascade of events, including intracranial hypertension, global cerebral ischemia, disruption of the blood–brain barrier", "score": 0.4256297 }, { "number": 13, "title": "Neurocardiology: Major mechanisms and effects", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0022073624003066", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "La Presse Médicale Formation, Volume 6, Issue 4, 2025, Article 100689 Benoit Lequeux, Thierry Garban View PDF \n ### The vulnerability of the human _taenia coli_ to alterations in total collagen within the colon of the elderly\n\nActa Histochemica, Volume 124, Issue 8, 2022, Article 151958 Nichola", "score": 0.28814873 }, { "number": 14, "title": "Decoding Stroke Etiology: Multi‐Omics Advancements in ...", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/10.1002/brb3.70792", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com", "snippet": "This review systematically presents multi-omics achievements in understanding the genetic susceptibility to stroke, Hypertension, diabetes,", "score": 0.07248569 }, { "number": 15, "title": "Papilledema is not the point: intracranial pressure ...", "detail": "academic.oup.com", "url": "https://academic.oup.com/braincomms/article/8/4/fcag259/8726050", "authors": "academic.oup.com", "host": "academic.oup.com", "snippet": "Radiological signs supporting idiopathic intracranial hypertension in symptomatic patients with lumbar puncture opening pressure <250 mm.", "score": 0.6959795 }, { "number": 16, "title": "Hypertonic saline versus mannitol for the... : Critical Care ...", "detail": "journals.lww.com", "url": "https://journals.lww.com/ccmjournal/fulltext/2011/03000/hypertonic_saline_versus_mannitol_for_the.18.aspx", "authors": "journals.lww.com", "host": "journals.lww.com", "snippet": "by H Kamel · 2011 · Cited by 471 — We found that hypertonic saline is more effective than mannitol for the treatment of elevated intracranial pressure.", "score": 0.586926 }, { "number": 17, "title": "Role of hypertonic saline and mannitol in the...", "detail": "journals.lww.com", "url": "https://journals.lww.com/jopn/fulltext/2010/05010/role_of_hypertonic_saline_and_mannitol_in_the.3.aspx", "authors": "journals.lww.com", "host": "journals.lww.com", "snippet": "by P Upadhyay · 2010 · Cited by 61 — Objective: To compare the efficacy and side effects of 3% hypertonic saline and mannitol in the management of raised intracranial pressure in children.", "score": 0.49523994 }, { "number": 18, "title": "Hypertonic Saline Associated with Superior Intracranial ...", "detail": "journals.lww.com", "url": "https://journals.lww.com/neurotodayonline/blog/breakingnews/pages/post.aspx?PostID=1218", "authors": "journals.lww.com", "host": "journals.lww.com", "snippet": "Hypertonic saline therapy was associated with greater decreases in intracranial pressure (ICP) in children with severe traumatic brain injury (", "score": 0.46482924 }, { "number": 19, "title": "Comparison of Equimolar Doses of Mannitol and ...", "detail": "journals.lww.com", "url": "https://journals.lww.com/md-journal/_layouts/15/oaks.journals/downloadpdf.aspx?an=00005792-201505010-00004", "authors": "journals.lww.com", "host": "journals.lww.com", "snippet": "by M Li · 2015 · Cited by 110 — Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury.", "score": 0.432807 }, { "number": 20, "title": "Intracranial Hypertension - StatPearls - NCBI Bookshelf - NIH", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK507811", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov", "snippet": "Idiopathic Intracranial Hypertension\n\nA brain MRI, with and without contrast, provides a detailed intracranial view when evaluating chronic causes of intracranial hypertension (see Image. Idiopathic Intracranial Hypertension MRI). A lumbar puncture is recommended for diagnosis, allowing for measurin", "score": 0.79732054 }, { "number": 21, "title": "Idiopathic Intracranial Hypertension Without Papilledema: A Case Emphasizing the Diagnostic Value of Optic Nerve Sheath Ultrasound", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12357743", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov", "snippet": "## , including postural headache and pulsatile tinnitus, but notably without papilledema. Initial investigations, including optical coherence tomography (OCT) of the optic nerve and computed tomography (CT) of the head, were unremarkable, resulting in a delay in diagnosis. Due to persistent symptoms", "score": 0.79080546 }, { "number": 22, "title": "Idiopathic intracranial hypertension in children: Diagnostic and management approach - PMC", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5237838", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov", "snippet": "and liver function tests. Thyroid function was normal with negative thyroid antibodies. Vitamin A level was 1.94 mmol/l (normal 1–2 mmol/l) and vitamin D level was 18.6 nmol/(75–250 nmol/l). Antinuclear antibodies (ANA), anti-double stranded DNA (dsDNA), complements 3 and 4 (C3, C4) were all normal.", "score": 0.77893573 }, { "number": 23, "title": "Papilledema and Idiopathic Intracranial Hypertension", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10564025", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov", "snippet": "## are common.\n\n The preferred nonemergent neuroimaging test for patients with papilledema is MRI. A contrast-enhanced MRI and venous imaging may also be needed, depending on the clinical situation. Orbital imaging with contrast is helpful for suspected infectious or inflammatory (optic neuritis)", "score": 0.7781275 }, { "number": 24, "title": "MRI findings as markers of idiopathic intracranial hypertension", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7856277", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov", "snippet": "IIH is diagnosed on the basis of high intracranial pressure, measured via lumbar puncture, and the absence of mass occupying lesion or venous thrombosis on neuro-imaging, normal cerebrospinal fluid, and no other secondary cause. Early criteria for IIH (The Modified Dandy Criteria) incorporated the u", "score": 0.77446437 } ], "publishedAt": "2026-08-24T16:32:17.680400+00:00", "updatedAt": "2026-08-24T16:32:17.680400+00:00", "readingMinutes": 6, "slug": "intracranial-hypertension" }